Why Is Redhill Biopharma (RDHL) Stock Up 32% Today?

Advertisement

  • Redhill Biopharma (RDHL) stock is rocketing on news from the U.S. Patent and Trademark Office (USPTO).
  • The company got a Notice of Allowance for a patent covering RHB-204.
  • RHB-204 is RedHill’s treatment for pulmonary Mycobacterium avium Complex (MAC) disease currently in development.
colorful pills and vials sitting on a table representing RDHL stock

Source: Bukhta Yurii / Shutterstock.com

Redhill Biopharma (NASDAQ:RDHL) stock is rocketing higher on Friday after getting positive patent news from the U.S. Patent and Trademark Office (USPTO).

Specifically, the USPTO has issued a Notice of Allowance that grants the company a patent for RHB-204’s treatment methods. This is the company’s treatment for pulmonary Mycobacterium avium Complex (MAC) disease.

The patent also covers the kits containing fixed-dose combination products to treat MAC. Redhill Biopharma says this patent will offer protection for RHB-204 through 2041.

RHB-204 is currently undergoing a Phase 3 clinical trial. Redhill Biopharma is also already in discussions with several possible partners for the distribution of the drug across different territories.

What This Means for RDHL Stock

Redhill Biopharma getting patent protection for one of its treatments is a win for RDHL stock investors. It means the company likely won’t have to deal with a generic version of its treatment until the protection wears off.

Also, the patent filing suggests that Redhill is expecting positive news from the Phase 3 clinical trial. If those results are good, investors could see shares of RDHL stock undergo another rally. The same would likely be true if the company announces partnerships for different territories.

Today’s news has RDHL stock seeing heavy trading, too. As of this writing, more than 17 million shares have changed hands. For the record, the daily average trading volume is about 3.4 million shares.

RDHL stock is up 31.7% during pre-market trading on Friday.

Investors seeking more of the latest stock market news will want to keep reading!

InvestorPlace is home to all of the most recent stock news traders need to know about on Friday! That includes this morning’s biggest pre-market stock movers, as well as the latest coverage of Occupy SEC 2023 and Akanda (NASDAQ:AKAN) stock. You can find out more on these matters at the links below!

More Friday Stock Market News

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.


Article printed from InvestorPlace Media, https://investorplace.com/2023/01/why-is-redhill-biopharma-rdhl-stock-up-32-today/.

©2024 InvestorPlace Media, LLC